fluoxetine and risperidone

fluoxetine has been researched along with risperidone in 84 studies

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	14 (16.67)	18.2507
2000's	32 (38.10)	29.6817
2010's	35 (41.67)	24.3611
2020's	3 (3.57)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Keserü, GM	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H	1
Jia, L; Sun, H	1
Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J	1
Ahman, M; Holmén, AG; Wan, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F	1
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ	1
Sen, S; Sinha, N	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Cai, G; Fan, M; Fang, F; Huang, Z; Li, W; Li, Y; Li, Z; Lian, J; Liu, Z; Lv, X; Qiu, Y; Wang, Y; Xu, X; Zhang, G; Zhang, L; Zheng, R	1
Giakas, WJ	1
Daniel, DG; Egan, M; Hyde, T; Smith, K	1
Bourgeois, JA; Klein, M	1
Pies, R	1
O'Connor, M; Silver, H	1
Caley, CF	1
Andrade, C	1
Dubbelman, YD; Heeringa, M; Thung, FH	1
Chang, WH; Lane, HY; Liu, CC	1
Benazzi, F	1
Blatt, SD; Botash, AS; Church, CC; Jean-Louis, F; Meguid, V; Siripornsawan, MP; Weinberger, HL	1
Nelson, JC; Ostroff, RB	1
Mahendran, R	1
Epperson, CN; Fasula, D; McDougle, CJ; Price, LH; Wasylink, S	1
Bader, PI; Cangany, N; Dougherty, S; Jackson, CE; Raymond, G	1
Elliott, MA; Koran, LM; Ringold, AL	1
Bozikas, V; Karavatos, A; Petrikis, P	1
Baumann, P; Bertschy, G; Bondolfi, G; Eap, CB; Vermeulen, A; Zullino, D	1
Beijnen, JH; Kerbusch, T; Mathôt, RA; Meesters, EW; Otten, HM; Schellens, JH; van Kan, HJ	1
Ancione, M; Avenoso, A; Gatti, G; Madia, A; Perucca, E; Scordo, MG; Spina, E	1
Chouinard, G; Levy, E; Margolese, HC; Sultan, S	1
Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB	1
Baba, A; Hashimoto, H; Shintani, N; Tanaka, K	1
Kaplan, GB; McRoberts, RL; Smokler, HJ	1
Croarkin, P; Nam, T; Waldrep, D	1
Jolkkonen, J; Puurunen, K; Schallert, T; Sivenius, J; Zhao, CS	1
Duggal, HS	1
Dinca, O; Paul, M; Spencer, NJ	1
Dikeos, DG; Kostoulas, C; Masdrakis, V; Papadimitriou, GN; Papageorgiou, CC; Psarros, C; Soldatos, CR; Theleritis, CG	1
Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G	1
Adachi, YU; Higuchi, H; Kazama, T; Mimuro, S; Sato, S; Satomoto, M; Watanabe, K; Yamada, S	1
Barton, R	1
Preskorn, SH	1
Harvey, I; Lilford, R; Song, F	1
Hinrichs, JW; Loovers, HM; Scholten, B; van der Weide, J	1
Dhir, A; Kulkarni, SK	1
Coskun, M; Zoroglu, S	1
Dastgheib, SA; Ebrahimi, AA; Mowla, A; Pani, A	1
Barraco, A; Benazzi, F; Berk, M; Frye, MA; Tohen, M; Wang, W	1
Kenchaiah, BK; Kumar, S; Tharyan, P	1
Hopkins, T; Nasrallah, HA; Pixley, SK	1
Chadman, KK	1
Bruzek, JL; Jerome, RN; Krishnaswami, S; McPheeters, ML; Sathe, N; Veenstra-Vanderweele, J; Warren, Z	1
Chan, CH; Chou, PH; Lan, TH; Lin, BT	1
Cavanna, AE; Rickards, H; Worrall, R	1
Okada, T	1
Rogóż, Z; Skuza, G	1
Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T	1
Raghunath, A	1
Klimek, E; Kuśmierczyk, J; Nalepa, I; Rogóż, Z; Roman, A	1
Gądek-Michalska, A; Kabziński, M; Rachwalska, P; Rogóż, Z; Sadaj, W	1
Gołembiowska, K; Kamińska, K; Rogóż, Z	1
Cornelius, V; Smith, L; Taylor, DM; Young, AH	1
Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O	1
Askenazy, F; Dor, E; Fernandez, A; Menard, ML; Thümmler, S	1
Gangadhar, BN; Rao, MG; Rao, NP; Rao, SA; Varambally, S	1
Barcellos, HH; Barcellos, LJ; de Abreu, MS; de Oliveira, TA; Fagundes, M; Giacomini, AC; Gusso, D; Idalencio, R; Kalichak, F; Koakoski, G; Piato, AL; Rosa, JG	1
Cawkwell, P; Coffey, BJ; Lawler, A; Maneta, E	1
Kamińska, K; Pańczyszyn-Trzewik, P; Rogóż, Z; Sowa-Kućma, M	1
Sreeraj, VS; Uvais, NA	1
Lin, CM; Little, K; Reynolds, PM	1
Boustany, RM; Khalifeh, S; Kourtian, S; Yassin, W	1
Cheng, X; Dong, W; Feng, W; Li, H; Wang, M; Zhang, D	1
Bernardo, CO; Gonzalez-Chica, DA; Jureidini, J; Klau, J; Raven, M	1

Reviews

9 review(s) available for fluoxetine and risperidone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Sudden infant death syndrome, child sexual abuse, and child development. Current opinion in pediatrics, 1999, Volume: 11, Issue:2 Topics: Autistic Disorder; Child; Child Abuse, Sexual; Child, Preschool; Condylomata Acuminata; Fluoxetine; Humans; Infant; Infant, Newborn; Naltrexone; Narcotic Antagonists; Papillomaviridae; Papillomavirus Infections; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sudden Infant Death	1999
Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders. Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:5 Topics: Adolescent; Antipsychotic Agents; Child; Child Behavior Disorders; Child Development Disorders, Pervasive; Cross-Over Studies; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Randomized Controlled Trials as Topic; Reproducibility of Results; Risperidone; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome	2005
Use of medication in children with psychiatric disorders. Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association, 2007, Volume: 80, Issue:11 Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom	2007
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. Journal of clinical epidemiology, 2008, Volume: 61, Issue:5 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome	2008
A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics, 2011, Volume: 127, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Patient Compliance; Piperazines; Prognosis; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome	2011
[The mental disorder and obsessive-compulsive spectrum disorders in childhood ]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2011, Volume: 113, Issue:10 Topics: Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Clomipramine; Cognitive Behavioral Therapy; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors	2011
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta psychiatrica Scandinavica, 2014, Volume: 130, Issue:6 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid	2014
AUTISM IN REVIEW. Le Journal medical libanais. The Lebanese medical journal, 2016, Volume: 64, Issue:2 Topics: Aripiprazole; Autism Spectrum Disorder; Central Nervous System Agents; Diagnostic and Statistical Manual of Mental Disorders; Diffusion Tensor Imaging; Fluoxetine; Humans; Risk Factors; Risperidone; White Matter	2016

Trials

4 trial(s) available for fluoxetine and risperidone

Article	Year
Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:4 Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome	1999
Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases. Journal of child and adolescent psychopharmacology, 1999, Volume: 9, Issue:1 Topics: Adult; Chronic Disease; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Trichotillomania	1999
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:7 Topics: Adult; Benzodiazepines; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Weight Gain; Xerostomia	2000
The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients. Pharmacopsychiatry, 2002, Volume: 35, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Area Under Curve; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Fluoxetine; Hemodynamics; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Switzerland	2002

Other Studies

71 other study(ies) available for fluoxetine and risperidone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship	2003
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery. Journal of medicinal chemistry, 2007, Sep-20, Volume: 50, Issue:19 Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats	2007
Support vector machines classification of hERG liabilities based on atom types. Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11 Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve	2008
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors. European journal of medicinal chemistry, 2009, Volume: 44, Issue:6 Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship	2009
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution	2011
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3 Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results	2011
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Discovery of Novel and Potent Journal of medicinal chemistry, 2021, 05-13, Volume: 64, Issue:9 Topics: Action Potentials; Allosteric Regulation; Animals; Antidepressive Agents; Binding Sites; Cell Survival; Depressive Disorder, Major; Disease Models, Animal; Drug Evaluation, Preclinical; Furans; Half-Life; Humans; Maze Learning; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neurons; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship	2021
Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder. The American journal of psychiatry, 1995, Volume: 152, Issue:7 Topics: Adult; Antipsychotic Agents; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Risperidone; Tourette Syndrome; Treatment Outcome	1995
Neuroleptic-induced tardive dyskinesia. The American journal of psychiatry, 1996, Volume: 153, Issue:5 Topics: Adolescent; Basal Ganglia Diseases; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Male; Risperidone; Schizophrenia	1996
Risperidone and fluoxetine in the treatment of pedophilia with comorbid dysthymia. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Comorbidity; Dysthymic Disorder; Fluoxetine; Humans; Male; Pedophilia; Risperidone	1996
Re: Extrapyramidal side effects with low-dose risperidone. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1997, Volume: 42, Issue:8 Topics: Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Humans; Risperidone; Selective Serotonin Reuptake Inhibitors	1997
Adding risperidone to selective serotonin reuptake inhibitor improves chronic depression. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1 Topics: Adult; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	1998
Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1998, Volume: 43, Issue:3 Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Risperidone; Selective Serotonin Reuptake Inhibitors	1998
Risperidone may worsen fluoxetine-treated OCD. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:5 Topics: Acute Disease; Adult; Antipsychotic Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Risperidone; Severity of Illness Index	1998
[Severe tardive dyskinesia during treatment with risperidone and fluoxetine]. Nederlands tijdschrift voor geneeskunde, 1998, Jun-27, Volume: 142, Issue:26 Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Male; Risperidone; Schizophrenia	1998
Risperidone for exclusively negative symptoms. The American journal of psychiatry, 1999, Volume: 156, Issue:2 Topics: Adult; Antipsychotic Agents; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	1999
Gynecomastia with risperidone-fluoxetine combination. Pharmacopsychiatry, 1999, Volume: 32, Issue:1 Topics: Adult; Antipsychotic Agents; Drug Combinations; Fluoxetine; Gynecomastia; Humans; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Selective Serotonin Reuptake Inhibitors	1999
Obsessive-compulsive symptoms with risperidone. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:4 Topics: Antipsychotic Agents; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Risk Factors; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Valproic Acid	1999
Infantile refsum disease in four Amish sibs. American journal of medical genetics, 2000, Jan-17, Volume: 90, Issue:2 Topics: Adolescent; Antidepressive Agents; Child; Consanguinity; Female; Fluoxetine; Humans; Lorazepam; Male; Refsum Disease; Risperidone	2000
Urinary retention caused after fluoxetine-risperidone combination. Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Basal Ganglia Diseases; Delusions; Drug Combinations; Fluoxetine; Humans; Male; Middle Aged; Risperidone; Urinary Retention	2001
Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report. Pharmacology & toxicology, 2002, Volume: 90, Issue:5 Topics: Acute Disease; Acute Kidney Injury; Adult; Antimanic Agents; Antipsychotic Agents; Bayes Theorem; Bipolar Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Lithium; Lorazepam; Male; Models, Biological; Renal Dialysis; Risperidone; Suicide, Attempted	2002
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:4 Topics: Adult; Antipsychotic Agents; Depression; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric	2002
Obsessive-compulsive symptoms in schizophrenia induced by risperidone and responding to fluoxetine. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:10 Topics: Antipsychotic Agents; Chronic Disease; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors	2003
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2003, Volume: 103, Issue:11 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride	2003
[Altered behavioral response to centrally acting drugs in mice lacking PACAP]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122 Suppl Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Fluoxetine; Haloperidol; Mice; Mice, Knockout; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Risperidone	2003
Baclofen as adjunctive treatment for a patient with cocaine dependence and schizoaffective disorder. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:5 Topics: Alcoholism; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Baclofen; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Follow-Up Studies; GABA Agonists; Humans; Long-Term Care; Male; Marijuana Abuse; Middle Aged; Risperidone; Secondary Prevention	2004
Comment on adult baby syndrome. The American journal of psychiatry, 2004, Volume: 161, Issue:11 Topics: Adult; Antipsychotic Agents; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Paraphilic Disorders; Psychotherapy; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2004
Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury. Behavioural brain research, 2005, Mar-30, Volume: 158, Issue:2 Topics: Affect; Aggression; Aging; Animals; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; Brain; Brain Ischemia; Cerebral Infarction; Drug Interactions; Fluoxetine; Male; Maze Learning; Postural Balance; Psychomotor Performance; Rats; Rats, Wistar; Risperidone; Thrombosis	2005
Cognitive affective psychosis syndrome in a patient with sporadic olivopontocerebellar atrophy. The Journal of neuropsychiatry and clinical neurosciences, 2005,Spring, Volume: 17, Issue:2 Topics: Adolescent; Affective Disorders, Psychotic; Anti-Dyskinesia Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cerebellum; Female; Fluoxetine; Hallucinations; Humans; Olivopontocerebellar Atrophies; Paranoid Disorders; Risperidone; Tomography, X-Ray Computed; Trihexyphenidyl	2005
Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: case report. BMC psychiatry, 2006, Sep-05, Volume: 6 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bulimia; Depression; Diabetes Mellitus; Female; Fluoxetine; Humans; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome; Weight Gain	2006
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. Pharmacy world & science : PWS, 2008, Volume: 30, Issue:1 Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome	2008
Isoflurane anesthesia inhibits clozapine- and risperidone-induced dopamine release and anesthesia-induced changes in dopamine metabolism was modified by fluoxetine in the rat striatum: an in vivo microdialysis study. Neurochemistry international, 2008, Volume: 52, Issue:3 Topics: Anesthetics, Inhalation; Animals; Chromatography, High Pressure Liquid; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Fluid; Fluoxetine; Isoflurane; Male; Microdialysis; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Synaptic Transmission	2008
Deconstructing a medication regimen. Journal of psychiatric practice, 2008, Volume: 14, Issue:2 Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benztropine; Biotransformation; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Carbonate; Metabolic Clearance Rate; Ranitidine; Risperidone; Stupor; Valproic Acid	2008
Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics. European journal of clinical pharmacology, 2008, Volume: 64, Issue:10 Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Cytochrome P-450 CYP2D6; Fluoxetine; Gene Dosage; Gene Frequency; Genotype; Humans; Middle Aged; Models, Genetic; Phenotype; Polymorphism, Genetic; Predictive Value of Tests; Psychotropic Drugs; Risperidone; Venlafaxine Hydrochloride; Young Adult	2008
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors. Neuroscience letters, 2008, Nov-07, Volume: 445, Issue:1 Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Immobility Response, Tonic; Locomotion; Male; Mice; Receptors, Adrenergic, alpha-2; Risperidone; Swimming; Venlafaxine Hydrochloride; Yohimbine	2008
Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder. Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:3 Topics: Antipsychotic Agents; Child, Preschool; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Inhibition, Psychological; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Statistics, Nonparametric	2009
Nasal bleeding associated with fluoxetine and risperidone interaction: a case report. Pharmacopsychiatry, 2009, Volume: 42, Issue:5 Topics: Depression; Drug Interactions; Epistaxis; Fluoxetine; Follow-Up Studies; Humans; Male; Risperidone; Schizophrenia; Serotonin Agents; Treatment Outcome; Young Adult	2009
Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:10 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Olanzapine; Placebos; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome	2009
Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients. International journal of dermatology, 2010, Volume: 49, Issue:1 Topics: Antipsychotic Agents; Benzodiazepines; Ectoparasitic Infestations; Female; Fluoxetine; Haloperidol; Humans; Imipramine; Male; Middle Aged; Olanzapine; Pimozide; Retrospective Studies; Risperidone; Schizophrenia, Paranoid; Sertraline	2010
Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats. Brain research, 2010, Oct-01, Volume: 1354 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Cell Count; Cell Proliferation; Dose-Response Relationship, Drug; Fluoxetine; Hippocampus; Isoxazoles; Lateral Ventricles; Male; Neurogenesis; Neurons; Olfactory Mucosa; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors	2010
Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacology, biochemistry, and behavior, 2011, Volume: 97, Issue:3 Topics: Animals; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Fluoxetine; Male; Mice; Risperidone; Social Behavior	2011
Chronic Cotard's syndrome: recovery from 2 years' bed-ridden status. Psychiatry and clinical neurosciences, 2011, Volume: 65, Issue:3 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chronic Disease; Delusions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Risperidone; Syndrome	2011
Treatment practices in Tourette syndrome: the European perspective. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome	2012
Anxiolytic-like effects of olanzapine, risperidone and fluoxetine in the elevated plus-maze test in rats. Pharmacological reports : PR, 2011, Volume: 63, Issue:6 Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Male; Maze Learning; Olanzapine; Rats; Rats, Wistar; Risperidone; Treatment Outcome	2011
Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models. Neuroscience letters, 2012, Oct-18, Volume: 528, Issue:1 Topics: 5-Hydroxytryptophan; Animals; Brain; Clorgyline; Disease Models, Animal; Fluoxetine; Glutamic Acid; Male; Microdialysis; Monoamine Oxidase Inhibitors; Nitric Oxide; Rats, Wistar; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Tranylcypromine	2012
Repeated activation of mania by atypical antipsychotics in a patient. BMJ case reports, 2012, Nov-27, Volume: 2012 Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Substitution; Drug Therapy, Combination; Female; Fluoxetine; Humans; Loxapine; Medication Adherence; Middle Aged; Olanzapine; Recurrence; Risperidone; Schizophrenia	2012
Effects of co-administration of fluoxetine and risperidone on properties of peritoneal and pleural macrophages in rats subjected to the forced swimming test. Pharmacological reports : PR, 2012, Volume: 64, Issue:6 Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Arginase; Behavior, Animal; Cells, Cultured; Colorimetry; Depression; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Leukocyte Count; Macrophages; Macrophages, Peritoneal; Male; Nitric Oxide; Phenotype; Pleural Cavity; Rats; Rats, Wistar; Risperidone; Stress, Psychological; Superoxides; Swimming	2012
Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test. Pharmacological reports : PR, 2012, Volume: 64, Issue:6 Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Exploratory Behavior; Fluoxetine; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Swimming	2012
Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex. Pharmacological reports : PR, 2013, Volume: 65, Issue:5 Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dopamine; Drug Interactions; Fluoxetine; Male; Microdialysis; Norepinephrine; Prefrontal Cortex; Rats; Rats, Wistar; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors	2013
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation. Therapeutic drug monitoring, 2015, Volume: 37, Issue:3 Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline	2015
[Carbamazepine and psychotropic treatment interaction: Two case studies of carbamazepine overdosage]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2015, Volume: 22, Issue:5 Topics: Adolescent; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Overdose; Drug Therapy, Combination; Female; Fluoxetine; Humans; Loxapine; Mental Disorders; Risperidone	2015
Successful treatment of tuberous sclerosis with psychosis and obsessive-compulsive disorder: A case report. Psychiatry and clinical neurosciences, 2015, Volume: 69, Issue:8 Topics: Adult; Antipsychotic Agents; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Risperidone; Tuberous Sclerosis	2015
Waterborne psychoactive drugs impair the initial development of Zebrafish. Environmental toxicology and pharmacology, 2016, Volume: 41 Topics: Animals; Diazepam; Embryo, Nonmammalian; Embryonic Development; Female; Fluoxetine; Larva; Male; Mortality; Psychotropic Drugs; Risperidone; Water Pollutants, Chemical; Zebrafish	2016
Staying Up at Night: Overlapping Bipolar and Obsessive-Compulsive Disorder Symptoms in an Adolescent with Autism Spectrum Disorder. Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:1 Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Autism Spectrum Disorder; Bipolar Disorder; Depressive Disorder, Major; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Risperidone; Sleep Initiation and Maintenance Disorders	2016
Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats. Pharmacological reports : PR, 2017, Volume: 69, Issue:5 Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Drug Interactions; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Hippocampus; Mianserin; Mirtazapine; Rats; Rats, Wistar; Risperidone; RNA, Messenger; Serotonin Antagonists	2017
Obsessive-compulsive disorder presenting with gender incongruence obsessions. Asian journal of psychiatry, 2017, Volume: 30 Topics: Adult; Antipsychotic Agents; Fluoxetine; Gender Identity; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Young Adult	2017
Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose. The American journal of case reports, 2018, May-25, Volume: 19 Topics: Benzodiazepines; Bupropion; Cyproheptadine; Dopamine Uptake Inhibitors; Drug Overdose; Fluoxetine; Humans; Male; Olanzapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Serotonin Syndrome; Time Factors; Trazodone; Young Adult	2018
A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic. Current pharmaceutical biotechnology, 2020, Volume: 21, Issue:1 Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Citalopram; Drug Monitoring; Fluoxetine; Humans; Risperidone; Tandem Mass Spectrometry	2020
Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018. The Australian and New Zealand journal of psychiatry, 2022, Volume: 56, Issue:11 Topics: Adolescent; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Australia; Benzodiazepines; Child; Child, Preschool; Drug Prescriptions; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Melatonin; Primary Health Care; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone	2022